Shandong Lukang Pharmaceutical Co., Ltd. Class ASSE: 600789

Announcement on Reception of Investor Research

Apr 3, 2025 · Issued by Shandong Lukang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Reception of Investor Research

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment